Clinical Trial Update: Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating repeated intravenous thrombolysis with tenecteplase for ischemic stroke presenting within 4.5 hours, focusing on medium-to-lar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: Ischemic Stroke | Phase 2 | Status: RECRUITING